Ratings Charles River Laboratories International, Inc.

Equities

CRL

US1598641074

Market Closed - Nyse 04:00:02 2024-06-14 pm EDT 5-day change 1st Jan Change
209.5 USD -1.40% Intraday chart for Charles River Laboratories International, Inc. -2.48% -11.39%

Summary

  • The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • The company's earnings growth outlook lacks momentum and is a weakness.
  • With a 2024 P/E ratio at 26.34 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Biotechnology & Medical Research

1st Jan change Capi. Investor Rating ESG Refinitiv
-11.39% 10.79B
C+
+40.80% 53.67B
B-
+35.79% 38.86B
A
-8.05% 38.76B
B
-8.98% 27.27B
C
+10.69% 25.91B
B-
-16.21% 20.29B
B
+31.00% 12.78B
B+
+28.51% 12.18B
C+
-1.67% 11.96B
B+
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. CRL Stock
  4. Ratings Charles River Laboratories International, Inc.